Download PDF
Thromb Haemost 1998; 80(04): 603-606
DOI: 10.1055/s-0037-1615429
Rapid Communication
Schattauer GmbH

Association of Overall Adiposity rather than Body Mass Index with Lipids and Procoagulant Factors

F. De Lorenzo
1   From the Thrombosis Research Institute
,
M. Mukherjee
1   From the Thrombosis Research Institute
,
Z. Kadziola
1   From the Thrombosis Research Institute
,
S. Suleiman
1   From the Thrombosis Research Institute
,
V. V Kakkar
1   From the Thrombosis Research Institute
2   From the Beatrice Research Centre, London, UK
› Author Affiliations
Further Information

Publication History

Received 16 February 1998

Accepted after resubmission 09 June 1998

Publication Date:
08 December 2017 (online)

    Permissions and Reprints

Summary

The association between obesity and risk of coronary artery disease is well established. The distribution of body fat was shown to be related to serum lipids and lipoproteins in a group of healthy men, but the association between body fat and haemostatic factors is less clear. The aim of the present study was to determine the association of overall adiposity (OVRAD, percent total fat mass contributing to body weight) and body mass index (BMI, weight/height2) with lipids and haemostatic factors in order to evaluate which of these was more associated with circulating procoagulant factors. The total fat mass was estimated by dual-energy X-ray absorptiometry (DEXA) and OVRAD computed for 28 male and 36 healthy female subjects, whose median age were 44.2 years and 48.4 years respectively. In addition, the BMI was computed for each of them from their weight and height measurements. Fasting samples were analysed for serum lipids (total, HDL- and LDL-cholesterol and triglyceride) and plasma fibrinogen, factor VII coagulant (FVII:C) activity, tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) activities. The men and women had similar median BMI (23.9 kg/m2 and 23.1 kg/m2 respectively), but the median fat mass of women (19.6 kg ) was higher than that of men (16.9 kg). Age, BMI and OVRAD exhibited statistically significant correlations with lipids and haemostatic factors in both men and women. However, when BMI was adjusted for age and OVRAD, the statistically significant associations were no longer apparent in men or women. In contrast, OVRAD adjusted for age and BMI still exhibited statistically significant associations with FVII:C activity (R = 0.38, p = 0.05), triglyceride (R = 0.51, p = 0.008), LDLcholesterol (R = 0.45, p = 0.02) and HDL/Total cholesterol ratio (R = -0.63, p <0.001). It is concluded that OVRAD, a fat mass-based index, rather than BMI, a weight-height based index, is better associated with circulating coronary risk factors.

 

  • References

  • 1 Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in men and women- importance of regional adipose tissue distribution. J Clin Invest 1983; 72: 1150-62.
    CrossrefPubMedGoogle Scholar
  • 2 Peiris A, Meuller RA, Smith GA, Struve MF, Kissebah AH. Splanchnic insulin metabolism in obesity: influence of body fat distribution. J Clin Invest 1968; 78: 1648-57.
    PubMedGoogle Scholar
  • 3 Walton C, Lees B, Crook D, Worthington M, Godsland IF, Stevenson JC. Body fat distribution, rather than overall adiposity, influences serum lipids and lipoproteins in healthy men independently of age. Am J of Med 1995; 99: 459-64.
    CrossrefPubMedGoogle Scholar
  • 4 Brunzell JD, Fujimoto WY. Body fat distribution and dyslipidemia. Am J of Med 1995; 99: 457-8.
    CrossrefPubMedGoogle Scholar
  • 5 Krobot K, Hense HW, Cremer P, Eberle E, Keil U. Determinants of plasma fibrinogen: relation to body weight, waist to hip ratio, smoking, acohol, age and sex-Results from the second MONICA Ausburg Survey, 1989-1990. Arterioscler Thromb 1992; 12: 780-8.
    CrossrefPubMedGoogle Scholar
  • 6 Folsom AR, Wu KK, Shahar E, Davis CE. for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Association of haemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. Arterioscl Thromb 1993; 13: 1829-36.
    CrossrefPubMedGoogle Scholar
  • 7 Green D, Ruth KJ, Folsom AR, Liu K. Haemostatic factors in the coronary artery risk development in young adults (CARDIA) study. Arterioscl Thromb 1994; 14: 686-93.
    CrossrefPubMedGoogle Scholar
  • 8 Bara L, Nicaud V, Tiret L, Cambien F, Samama MM. On behalf of the EARS Group. Expression of a paternal history of premature myocardial infarction on fibrinogen, factor VIIc and PAI-1 in European offspring – The EARS study. Thromb Haemost 1994; 71: 434-40.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, WU KK. Association of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993; 70: 380-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Avellone G, Di Garbo V, Cordova R, Ranelli G, De Simone R, Bompiani GD. Coagulation, fibrinolysis and haemorheology in premenopausal women with different body fat distribution. Thromb Res 1994; 75: 223-31.
    CrossrefPubMedGoogle Scholar
  • 11 Eliasson M, Evrin PE, Lundbald D. Fibrinogen and fibrinolytic variables in relation to anthropometry lipids and blood pressure. The Northern Sweden Monica Study. J Clin Epidemiol 1994; 47: 513-24.
    CrossrefPubMedGoogle Scholar
  • 12 Cigolini M, Targher G, Bergamo-Andreis IA, Tonoli M, Agostino G, De Sandre G. Visceral fat accumulation and its relation to plasma haemostatic factors in healthy men. Arterioscler Thromb Vasc Biol 1996; 16: 368-74.
    CrossrefPubMedGoogle Scholar
  • 13 Blann AD, Bushell D, Davies A, Faragher EB, Miller JP, McCollum CN. Von Willebrand factor, the endothelium and obesity. Int J Obes 1993; 17: 723-7.
    PubMedGoogle Scholar
  • 14 Vague P, Juhan-Vague I, Aillaud MF, Badier C, Viard R, Alessi MC, Collen D. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism 1986; 35: 250-3.
    CrossrefPubMedGoogle Scholar
  • 15 Vague P, Juhan-Vague I, Chabert V, Alessi C. Fat distribution and plasminogen activator inhibitor activity in nondiabetic women. Metabolism 1989; 38: 913-5.
    CrossrefPubMedGoogle Scholar
  • 16 Landin K, Stigenal L, Eriksson E, Krotkiewski M, Risberg B, Tengborn L, Smith U. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 1990; 39: 1044-8.
    CrossrefPubMedGoogle Scholar
  • 17 De Pergola G, De Mitrio V, Perricci A, Cignarelli M, Garruti G, Lomuscio S, Ferri G, Schiraldi O, Giorgino R. Influence of free testosterone on antigen levels of plasminogen activator inhibitor-1 (PAI-1) in premenopausal women with central obesity. Metabolism 1992; 41: 131-4.
    CrossrefPubMedGoogle Scholar
  • 18 De Pergola G, De Mitrio V, Cignarelli M, Garruti F, Giorgino F, Meola M, Giorgino R. Inverse relationship between cortisol excretion rate and plasminogen activator inhibitor-1 (PAI-1) in premenopausal obese women. Int J Obes 1991; 15: 619-22.
    PubMedGoogle Scholar
  • 19 Folsom AR, Qamlieh HT, Wing RR, Jeffrey RW, Stinson VL, Kuller LH, Wu KK. Impact of weight loss on plasminogen activator inhibitor-1 (PAI-1), factor VII and other haemostatic factors in moderately overweight adults. Arterioscler Thromb 1993; 13: 162-9.
    CrossrefPubMedGoogle Scholar
  • 20 Sundell IB, Nilsson TK, Ranby M, Hallmans G, Hellsten G. Fibrinolytic variables are related to age, sex, blood pressure, and body build measurements: a cross sectional study in Norsjo Sweden. J Clin Epidemiol 1989; 42: 719-23.
    CrossrefPubMedGoogle Scholar
  • 21 DeLorenzo F, Mukherjee M, Kadziola Z, Kakkar VV. Association of DEXA-assessed total body fat mass with serum lipids and haemostatic variables. Blood Coag Fibrinol. 1998 In press.
    PubMedGoogle Scholar
  • 22 Friedwald WT, Levy RI, Fredrickson D. Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
    PubMedGoogle Scholar
  • 23 Mukherjee M, Sembhi K, Kakkar VV. Interference of an activity assay of tissue-type plasminogen activator in human plasma by endogenous factors. Blood Coag Fibrinol 1996; 7: 491-6.
    CrossrefPubMedGoogle Scholar
  • 24 Mukherjee M, Dastur DK, Soneji SL. Identification of persons at high risk of coronary heart disease - A mathematical formula based on biochemical, anthropometric and clinical markers. J Assoc Phy India 1996; 44: 12-8.
    PubMedGoogle Scholar
  • 25 Han TS, van Leer EM, Seidell JC, Lean MEJ. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. Brit Med J 1995; 311: 1401-5.
    CrossrefPubMedGoogle Scholar
  • 26 Sjostrom CD, Hankangard C, Lissner L, Sjostrom L. Body compartment and subcutaneous adipose tissue distribution – risk factor patterns in obese subjects. Obesity Res 1995; 3: 9-22.
    PubMedGoogle Scholar
  • 27 Mukherjee M, Dastur DK. Atherogenic markers in the offspring vis-a-vis family history of coronary heart disease. Int J Cardiol 1994; 44: 65-71.
    CrossrefPubMedGoogle Scholar
  • 28 Durenberg P, Westrate JA, Seidell JC. Body mass index as a measure of body fatness: Age-and sex-specific prediction formulas. Brit J Nutr 1991; 65: 105-14.
    CrossrefPubMedGoogle Scholar
  • 29 Douchi T, Ijuin H, Nakamura S, Oki T, Yamamoto S, Katanozaka M, Nagata Y. The relation between body-fat distribution and lipid metabolism in postmenopausal women. J Obstet Gynaecol Res 1996; 22: 353-8.
    CrossrefPubMedGoogle Scholar
  • 30 Mukherjee M, Dawsn G, Sembhi K, Kakkar VV. Triglyceride dependence of factor VII coagulant activity in deep venous thrombosis. Thromb Haemost 1996; 76: 500-1.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Mukherjee M, Scully MF, Kakkar VV, Phillipou H, Lane DA, Jewitt D. Decrease in factor VII coagulant activity during percutaneous coronary angioplasty by heparin-mediated lipolytic action. Thromb Haemost 1997; 77: 675-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Behnke AR, Wilmore JH. Evaluation and regulation of body build and composition. New Jersey: Prentice-Hall Inc.; 1974
    Google Scholar
  • 33 Dru Marshall J, Hazlett CB, Spady DW, Conger PR, Quinney HA. Validity of convenient indicators of obesity. Human Biol 1991; 63: 137-53.
    PubMedGoogle Scholar
  • 34 Owen OE, Obesity. In: Kinney JM, Jeejeebhy KN, Hill GL. Philadelphia: W. B. Saunders; 1988: 167-92.
    PubMed
  • 35 Durnin JVGA, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: Measurement on 481 men and women aged 16 to 72 years. Br J Nutr 1974; 32: 77-97.
    CrossrefPubMedGoogle Scholar
  • 36 Roubenoff R, Dallal GE, Wilson PWF. Predicting body fatness: The body mass index vs estimation by biolectrical impedance. Am J Public Health 1995; 85: 726-8.
    CrossrefPubMedGoogle Scholar
  • 37 Stewart SP, Bramley PN, Heighton R, Green JH, Horsman A, Losowsky MS, Smith MA. Estimation of body composition from biolectrical impedance of body segments: Comparison with dual-energy X-ray absorptiometry. Br J Nutr 1993; 69: 645-55.
    CrossrefPubMedGoogle Scholar
  • 38 Spungen AM, Bauman WA, Wang J, Pierson Jr. RN. Measurement of body fat in individuals with tetraplegia: A comparison of eight clinical methods. Paraplegia 1995; 33: 402-8.
    PubMedGoogle Scholar
  • 39 Chertow GM, Lowrie EG, Wilmore DW, Gonzalez J, Lew NL, Ling J, Leboff MS, Gottlieb MN, Huang W, Zebrowski B. Nutritional assessment with biolectrical impedance analysis in maintenance hemodialysis patients. J Am Soc Nephrol 1995; 6: 75-81.
    PubMedGoogle Scholar